Beijing Pason Pharmaceuticals Inc.

Beijing Pason Pharmaceuticals Inc. (Pason) was established in 2001 by a group of outstanding scientists and successful entrepreneurs. Over the past 22 years, adhering to the belief of "Search for truth, Be pragmatic and innovative”, the company has always been committed to innovative research and development of early diagnosis and treatment of neurodegenerative diseases, infectious diseases, and cancers through cooperation with leading domestic and international research institutes, hospitals and companies. Pason has been providing customers with world-class technology and products, and its products and technology have been widely used in clinical research in China on the etiology, pathogenesis, and therapeutic drugs of neurological disorders, infectious diseases, and cancers.  

In the fields of early screening, diagnosis, diagnostics, and efficacy evaluation of concomitant disease treatment and prognosis assessment of neurodegenerative diseases, infectious diseases, and cancers, Pason not only provides customers with international gold standard products but also a high level of technical support, consultation, sample testing service, etc. The company's product quality and technical service level in the industry-leading position receive product users and business and research partners' praise. The company has been paying great attention to translational medicine and actively participates in interdisciplinary and cross-field cooperation. Pason has investments in several innovative research projects, including imaging tracers, new drugs for the treatment of Alzheimer’s disease and Parkinson's disease, next-generation immunodiagnostic instrument platforms, etc. Significant achievements have been made in technological innovation, new product development, operation, and sales. Pason Pharmaceuticals Inc. has entered the fast track of sustainable development.